
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
Income Statement | ||||||
Revenue | $19.5B | $16.8B | $16B | $3.7B | $4.1B | |
Gross Profit | $13.2B | $10.3B | $9.3B | $2.1B | $2.3B | |
Operating Income | $9.7B | $6.6B | $5.5B | $1.2B | $1.3B | |
EBITDA | $10.7B | $8.5B | $7.6B | $1.8B | $1.8B | |
Diluted EPS | $8.90 | $6.41 | $5.27 | $1.20 | $1.28 |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Balance Sheet | ||||||
Current Assets | $10.4B | $14B | $15B | $17.4B | $13.1B | |
Total Assets | $19.6B | $25.3B | $29.2B | $34.9B | $33.8B | |
Current Liabilities | $1.7B | $2.5B | $2.9B | $3.6B | $2.5B | |
Total Liabilities | $9.5B | $11.3B | $14B | $17.9B | $17.4B | |
Total Equity | $10.2B | $14B | $15.2B | $17B | $16.4B | |
Total Debt | $6.3B | $7.7B | $10.1B | $14.2B | $12.8B |
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
Cash Flow Statement | ||||||
Cash Flow Operations | $7.7B | $6.3B | $6.2B | $1B | $849M | |
Cash From Investing | -$1.9B | -$7.7B | $1.4B | -$3.3B | $1.3B | |
Cash From Financing | -$4.9B | -$552M | -$7.3B | $1.8B | -$2.5B | |
Free Cash Flow | $4.4B | $940M | $1.5B | -$231M | -$274M |
Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.
In the current month, TXN has received 12 Buy ratings 20 Hold ratings, and 3 Sell ratings. The TXN average analyst price target in the past 3 months is $191.83.
According to analysts, the consensus estimate is that Texas Instruments share price will drop to $191.83 per share over the next 12 months.
Analysts are divided on their view about Texas Instruments share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Texas Instruments is a Sell and believe this share price will rise from its current level to $125.00.
The price target for Texas Instruments over the next 1-year time period is forecast to be $191.83 according to 35 Wall Street analysts, 12 of them rate the stock a Buy, 3 rate the stock a Sell, and 20 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Texas Instruments is a Hold. 20 of 35 analysts rate the stock a Hold at this time.
You can purchase shares of Texas Instruments via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Texas Instruments shares.
Texas Instruments was last trading at $216.58 per share. This represents the most recent stock quote for Texas Instruments. Yesterday, Texas Instruments closed at $216.64 per share.
In order to purchase Texas Instruments stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.